Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Molecular Immunology
|
July 27, 2024
Inhibition of DNMT1 attenuates experimental food allergy
Linjing Li, Wenjing Pang, Lingzhi Xu, et al.
Cellular Immunology
|
March 15, 2025
USP14 inhibits sensitization-mediated degradation of KDM4D to epigenetically regulate dendritic cell tolerogenic capacity and mitigates airway allergy
Aizhi Zhang, Huanping Zhang, Le Liu, et al.
Scientific Reports
|
April 17, 2014
TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation
Huan-Ping Zhang, Yingying Wu, Jiangqi Liu, et al.
Biomaterials
|
May 24, 2024
Multifunctional nanogel loaded with cerium oxide nanozyme and CX3CL1 protein: Targeted immunomodulation and retinal protection in uveitis rat model
Yuanyuan Jin, Danyang Cai, Lihua Mo, et al.
Cell Communication and Signaling : CCS
|
December 19, 2024
Dust mite antigens endow dendritic cells with the capacity to induce a Th2 response by regulating their methylation profiles
Xiwen Zhang, Haoyue Zheng, Yixuan Dong, et al.
The Journal of Clinical Investigation
|
January 13, 2022
ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine
Jun Xu, Sek Man Su, Xin Zhang, et al.
Nature Communications
|
September 26, 2020
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
Jianlin Liu, Ragini Adhav, Kai Miao, et al.
Human Molecular Genetics
|
November 17, 2018
BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy
Xiaoling Xu, Eric Chen, Lihua Mo, et al.
Cell Death & Disease
|
March 29, 2025
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy
Lihua Mo, Min Deng, Ragini Adhav, et al.
Nature Communications
|
March 19, 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
Jianjie Li, Xiaodong Shu, Jun Xu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Molecular Immunology
|
July 27, 2024
Inhibition of DNMT1 attenuates experimental food allergy
Linjing Li, Wenjing Pang, Lingzhi Xu, et al.
Cellular Immunology
|
March 15, 2025
USP14 inhibits sensitization-mediated degradation of KDM4D to epigenetically regulate dendritic cell tolerogenic capacity and mitigates airway allergy
Aizhi Zhang, Huanping Zhang, Le Liu, et al.
Scientific Reports
|
April 17, 2014
TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation
Huan-Ping Zhang, Yingying Wu, Jiangqi Liu, et al.
Biomaterials
|
May 24, 2024
Multifunctional nanogel loaded with cerium oxide nanozyme and CX3CL1 protein: Targeted immunomodulation and retinal protection in uveitis rat model
Yuanyuan Jin, Danyang Cai, Lihua Mo, et al.
Cell Communication and Signaling : CCS
|
December 19, 2024
Dust mite antigens endow dendritic cells with the capacity to induce a Th2 response by regulating their methylation profiles
Xiwen Zhang, Haoyue Zheng, Yixuan Dong, et al.
The Journal of Clinical Investigation
|
January 13, 2022
ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine
Jun Xu, Sek Man Su, Xin Zhang, et al.
Nature Communications
|
September 26, 2020
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor
Jianlin Liu, Ragini Adhav, Kai Miao, et al.
Human Molecular Genetics
|
November 17, 2018
BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy
Xiaoling Xu, Eric Chen, Lihua Mo, et al.
Cell Death & Disease
|
March 29, 2025
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapy
Lihua Mo, Min Deng, Ragini Adhav, et al.
Nature Communications
|
March 19, 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
Jianjie Li, Xiaodong Shu, Jun Xu, et al.
Page
of 6